Background and Objectives Neurocardiogenic syncope is the major type of syncope and beta-blocker is initial drug of choice. However, the data generated from the studies so far could not represent the beneficial effects of beta-blocker, and the recurrence rate in the long term was not established. This study examined the long-term follow-up in patients with neurocardiogenic syncope with or without therapy and compared among the therapeutic strategies in preventing the relapse of syncope. Materials and method Among the 197 patients with neurocardiogenic syncope or presyncope, who underwent head-up tilt test HUT from Oct. 1994 to Sep. 1996, we investigated 125 patients 59 males and 66 females . They were either interviewed on the phone or answered the questionnaire. The mean age was 39 16 years old and the mean duration of follow-up was 19 5.9 months. Results Out of the 125 patients, 85 patients 68 turned out to be HUT-positive and 40 patients 32 , negative. In the course of the follow-up in the HUT-positive patients, the symptoms recurred in 2 10 of the 20 patients who continued medication, 4 25 of the 16 patients who had no medication, and 11 22.4 of the 49 patients who discontinued medication on the way. Out of the 20 HUT-positive patients who continued medication, the symptom recurred in 1 7
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